Logo

Combimatrix Slated to Receive $2.3M in Defense Dept. Funding

Jul 23, 2004

NEW YORK, July 23 (GenomeWeb News) - Combimatrix will receive $2.3 million from a US Defense Department spending bill that was slated to be passed by Congress this week, the company said yesterday.

 

The funding is for the company's development of a microarray-based biosensor system to monitor biological and chemical agents that could pose threats. The system is being developed both for testing in the field of combat as well as within the US.

 

Combimatrix was originally awarded a $5.9 million contract in March by the Defense Department to develop this system. This new, additin funding is for continued development of the system.

Breaking News
The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.